GLP-1 (Glucagon-Like Peptide-1) Is Physiologically Relevant for Chylomicron Secretion Beyond Its Known Pharmacological Role
出版年份 2021 全文链接
标题
GLP-1 (Glucagon-Like Peptide-1) Is Physiologically Relevant for Chylomicron Secretion Beyond Its Known Pharmacological Role
作者
关键词
-
出版物
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
Volume -, Issue -, Pages -
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2021-05-06
DOI
10.1161/atvbaha.121.316311
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Emerging Role of Lymphatics in the Regulation of Intestinal Lipid Mobilization
- (2020) Changting Xiao et al. Frontiers in Physiology
- Intestinal basolateral lipid substrate transport (BLST) is linked to chylomicron secretion and is regulated by apoC-III.
- (2019) Diana Li et al. JOURNAL OF LIPID RESEARCH
- Glucose and GLP-2 (Glucagon-Like Peptide-2) Mobilize Intestinal Triglyceride by Distinct Mechanisms
- (2019) Priska Stahel et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- ATGL/CGI-58-Dependent Hydrolysis of a Lipid Storage Pool in Murine Enterocytes
- (2019) Melanie Korbelius et al. Cell Reports
- An overview of GLP-1 agonists and recent cardiovascular outcomes trials
- (2019) Kelsey H Sheahan et al. POSTGRADUATE MEDICAL JOURNAL
- Intestinal lymph as a readout of meal-induced GLP-1 release in an unrestrained rat model
- (2018) Nino Jejelava et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- The endogenous preproglucagon system is not essential for gut growth homeostasis in mice
- (2017) Pernille Wismann et al. Molecular Metabolism
- New Insights into the Regulation of Chylomicron Production
- (2015) Satya Dash et al. Annual Review of Nutrition
- Central Nervous System Regulation of Intestinal Lipoprotein Metabolism by Glucagon-Like Peptide-1 via a Brain-Gut Axis
- (2015) S. Farr et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- GLP-1R Agonists Modulate Enteric Immune Responses Through the Intestinal Intraepithelial Lymphocyte GLP-1R
- (2015) Bernardo Yusta et al. DIABETES
- Genetics and Causality of Triglyceride-Rich Lipoproteins in Atherosclerotic Cardiovascular Disease
- (2014) Robert S. Rosenson et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Triglycerides and cardiovascular disease
- (2014) Børge G Nordestgaard et al. LANCET
- Liraglutide suppresses postprandial triglyceride and apolipoprotein B48 elevations after a fat-rich meal in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, cross-over trial
- (2013) K. Hermansen et al. DIABETES OBESITY & METABOLISM
- Exenatide, a Glucagon-like Peptide-1 Receptor Agonist, Acutely Inhibits Intestinal Lipoprotein Production in Healthy Humans
- (2012) Changting Xiao et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- GLP-1 and GLP-2 as Yin and Yang of Intestinal Lipoprotein Production: Evidence for Predominance of GLP-2-Stimulated Postprandial Lipemia in Normal and Insulin-Resistant States
- (2012) G. J. Hein et al. DIABETES
- Large-scale association analysis identifies new risk loci for coronary artery disease
- (2012) Panos Deloukas et al. NATURE GENETICS
- The Biogenesis of Chylomicrons
- (2010) Charles M. Mansbach et al. Annual Review of Physiology
- One-year treatment with exenatide vs. Insulin Glargine: Effects on postprandial glycemia, lipid profiles, and oxidative stress
- (2010) Mathijs C. Bunck et al. ATHEROSCLEROSIS
- The glucagon-like peptide 1 receptor is essential for postprandial lipoprotein synthesis and secretion in hamsters and mice
- (2009) J. Hsieh et al. DIABETOLOGIA
- Evidence that Intestinal Glucagon-Like Peptide-1 Plays a Physiological Role in Satiety
- (2008) Diana L. Williams et al. ENDOCRINOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now